43 related articles for article (PubMed ID: 8827871)
1. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
2. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary treatment results of relapsed or refractory acute leukemia using two and three drug regimens].
Mariańska B; Apel D; Seferyńska I; Maj S
Wiad Lek; 1998; 51(1-2):42-5. PubMed ID: 9608830
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
5. [Multi-agent combination chemotherapy for adult acute lymphoblastic leukemia--individualized chemotherapy].
Uzuka Y; Saito Y; Takahashi H; Komatsu M; Ito T; Toyota T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1917-23. PubMed ID: 2393309
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of relapsed AML and ALL].
Nishikawa K
Rinsho Ketsueki; 1996 Aug; 37(8):647-50. PubMed ID: 8827871
[No Abstract] [Full Text] [Related]
7. Treatment of relapsed and refractory acute myeloid leukemia in adults.
Lazzarino M; Morra E; Alessandrino EP; Merante S; Bernasconi P; Bonfichi M; Caldera D; Bernasconi C
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():121-3. PubMed ID: 2653487
[No Abstract] [Full Text] [Related]
8. [Hematologic tumors].
Ogawa M
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1416-21. PubMed ID: 14584273
[TBL] [Abstract][Full Text] [Related]
9. Mitoxantrone in the treatment of refractory and relapsed non-lymphoblastic acute leukaemia.
Pretnar J
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():59-60. PubMed ID: 2697403
[No Abstract] [Full Text] [Related]
10. Mitoxantrone and amsacrine: two important agents for the treatment of acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL).
Arlin ZA
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():57-9. PubMed ID: 2653519
[No Abstract] [Full Text] [Related]
11. Etoposide: fifteen years experience.
Bernasconi C
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():52-5. PubMed ID: 2653518
[No Abstract] [Full Text] [Related]
12. Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
Weiss M
Hematol Oncol Clin North Am; 2001 Feb; 15(1):1-7, v. PubMed ID: 11253603
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]